Stay updated on Elderly Breast Cancer: Pertuzumab Combo Clinical Trial
Sign up to get notified when there's something new on the Elderly Breast Cancer: Pertuzumab Combo Clinical Trial page.

Latest updates to the Elderly Breast Cancer: Pertuzumab Combo Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe additions show Revision: v3.3.3, and deletions remove the HHS Vulnerability Disclosure and Revision: v3.3.2, which are minor maintenance updates affecting site navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2) and removes the older entry (v3.2.0), updating the history list without altering study content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe top government funding/operating status notice was removed; the page’s study history and details remain the same.SummaryDifference0.6%

- Check74 days agoChange DetectedTwo screenshots indicate a minor UI/layout update to the Record History page, with the version history and study status data unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check102 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Elderly Breast Cancer: Pertuzumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elderly Breast Cancer: Pertuzumab Combo Clinical Trial page.